Antibodies under a microscope

Database

Filter by:

Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity

You are searching for:

  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search

  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search

  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search

  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

2571-2580 of 4090 results

Catalogue Number:

PX-TA1345

Category:

G

Proteo Genix logo

Coltuximab Biosimilar – Anti-CD19 mAb – Research Grade

Target: CD19
Target Alias Name: Coltuximab/SAR3419/CD19 /anti-CD19
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1159

Category:

G

Proteo Genix logo

Conatumumab Biosimilar – Anti-TNFRSF10B/ CD262 mAb – Research Grade

Target: TNFRSF10B/ CD262
Target Alias Name: Conatumumab/AMG 655/TRAIL-R2mAb/XG1-048 v w/TNFRSF10B/ CD262/anti-TNFRSF10B/ CD262
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1306

Category:

G

Proteo Genix logo

Concizumab Biosimilar – Anti-TFPI mAb – Research Grade

Target: TFPI
Target Alias Name: Concizumab/Anti-TFPI/NN7415/mab2021/TFPI/anti-TFPI
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1650

Category:

G

Proteo Genix logo

Coprelotamab Biosimilar – Anti-ERBB2 mAb – Research Grade

Target: ERBB2
Target Alias Name: Coprelotamab/IMMUNOGLOBULIN G1/ ANTI-(HUMAN TYROSINE KINASE RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL GB221 .GAMMA.1-CHAIN)/ DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GB221 .KAPPA.-CHAIN/ DIMER/ IMMUNOGLOBULIN G1-KAPPA/ ANTI-(HOMO SAPIENSERBB2 (EPIDERMAL GROWTH FACTOR RECEPTOR 2/ RECEPTOR TYROSINE PROTEIN KINASE ERBB-2/ EGFR2/ HER2/ HER-2/ P185CERBB2/ NEU/ CD340))/ HUMANIZED MONOCLONAL ANTIBODY/ERBB2/anti-ERBB2
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1/Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA2113

Category:

G

Proteo Genix logo

Coramitug Biosimilar – Anti-Transthyretin mAb – Research Grade

Target: Transthyretin
Species Reactivity: Human
Application: ELISA
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1468

Category:

G

Proteo Genix logo

Cosfroviximab Biosimilar – Anti-Zaire Ebola virus mAb – Research Grade

Target: Zaire Ebola virus
Target Alias Name: Cosfroviximab/c13C6-FR1-N/Zaire Ebola virus /anti-Zaire Ebola virus
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1584

Category:

G

Proteo Genix logo

Cosibelimab Biosimilar – Anti-CD274/ PD-L1/ B7-H1 mAb – Research Grade

Target: CD274/ PD-L1/ B7-H1
Target Alias Name: Cosibelimab /CK-301/CD274/ PD-L1/ B7-H1/anti-CD274/ PD-L1/ B7-H1
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1-lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1828

Category:

G

Proteo Genix logo

Crefmirlimab Biosimilar – Anti-CD8A mAb – Research Grade

Target: CD8A
Target Alias Name: Crefmirlimab//CD8A/anti-CD8A
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1269

Category:

G

Proteo Genix logo

Crenezumab Biosimilar – Anti-APP Abeta42 and Abeta40 mAb – Research Grade

Target: APP Abeta42 and Abeta40
Target Alias Name: Crenezumab/MABT5102A/RG7412/APP Abeta42 and Abeta40/anti-APP Abeta42 and Abeta40
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG4-kappa
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo

Catalogue Number:

PX-TA1829

Category:

G

Proteo Genix logo

Crexavibart Biosimilar – Anti-SARS-CoV-2 Spike RBD mAb – Research Grade

Target: SARS-CoV-2 Spike RBD
Target Alias Name: Crexavibart//SARS-CoV-2 Spike RBD/anti-SARS-CoV-2 Spike RBD
Species Reactivity: Human
Type: Primary Recombinant
Isotype/Mimetic: IgG1 Lambda
Host Species: Human
Animal-Derived Biomaterials Used: None
Sequence Available No
Original Discovery Method Unknown
Original Discovery Information Provided On Datasheet No
Antibody/Binder Origins: Unknown discovery source/method, In vitro recombinant expression
Proteo Genix logo